188 related articles for article (PubMed ID: 34575799)
1. Invasive Fungal Disease in Patients with Newly Diagnosed Acute Myeloid Leukemia.
Wasylyshyn AI; Linder KA; Kauffman CA; Richards BJ; Maurer SM; Sheffield VM; Benitez Colon L; Miceli MH
J Fungi (Basel); 2021 Sep; 7(9):. PubMed ID: 34575799
[TBL] [Abstract][Full Text] [Related]
2. [Breakthrough of invasive fungal disease with posaconazole as primary prophylaxis after induction chemotherapy for acute myeloid leukemia].
Pei RZ; Lu Y; Zhang PS; Liu XH; Chen D; Du XH; Sha KY; Li SY; Cao JJ; Chen LG; Zhuang XX; Tang SH
Zhonghua Nei Ke Za Zhi; 2020 Mar; 59(3):213-217. PubMed ID: 32146748
[No Abstract] [Full Text] [Related]
3. Invasive fungal disease in children with acute myeloid leukaemia: An Australian multicentre 10-year review.
Yeoh DK; Moore AS; Kotecha RS; Bartlett AW; Ryan AL; Cann MP; McMullan BJ; Thursky K; Slavin M; Blyth CC; Haeusler GM; Clark JE
Pediatr Blood Cancer; 2021 Nov; 68(11):e29275. PubMed ID: 34357688
[TBL] [Abstract][Full Text] [Related]
4. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of invasive fungal disease in haematologic patients.
Souza L; Nouér SA; Morales H; Simões B; Solza C; Queiroz-Telles F; Nucci M
Mycoses; 2021 Mar; 64(3):252-256. PubMed ID: 33141969
[TBL] [Abstract][Full Text] [Related]
6. Incidence and outcome of invasive fungal disease after front-line intensive chemotherapy in patients with acute myeloid leukemia: impact of antifungal prophylaxis.
Rodríguez-Veiga R; Montesinos P; Boluda B; Lorenzo I; Martínez-Cuadrón D; Salavert M; Pemán J; Calvillo P; Cano I; Acuña E; Villalba A; Piñana JL; Sanz J; Solves P; Senent L; Vicente A; Sempere A; Cervera J; Barragán E; Jarque I; Torres A; Sanz MA; Sanz GF
Ann Hematol; 2019 Sep; 98(9):2081-2088. PubMed ID: 31240471
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the implementation rate of primary antifungal prophylaxis and the prognosis of invasive fungal disease in acute leukemia patients in China.
Xu XH; Zhang L; Cao XX; Li J; Zhang W; Zhu TN; Cai HC; Chen M; Han X; Yang C; Han B; Zhang Y; Zhuang JL; Zhou DB; Duan MH
J Infect Chemother; 2017 Jun; 23(6):360-367. PubMed ID: 28341518
[TBL] [Abstract][Full Text] [Related]
8. Epidemiology of Invasive Fungal Diseases in Patients with Hematologic Malignancies and Hematopoietic Cell Transplantation Recipients Managed with an Antifungal Diagnostic Driven Approach.
Bergamasco MD; Pereira CAP; Arrais-Rodrigues C; Ferreira DB; Baiocchi O; Kerbauy F; Nucci M; Colombo AL
J Fungi (Basel); 2021 Jul; 7(8):. PubMed ID: 34436127
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of invasive fungal diseases in adults with newly diagnosed acute myeloid leukemia.
Miranti E; Ho DY; Enriquez K; Subramanian AK; Medeiros BC; Epstein DJ
Leuk Lymphoma; 2022 Sep; 63(9):2206-2212. PubMed ID: 35410569
[TBL] [Abstract][Full Text] [Related]
10. Incidence and outcome of invasive fungal diseases after allogeneic hematopoietic stem cell transplantation: A Swiss transplant cohort study.
Kuster S; Stampf S; Gerber B; Baettig V; Weisser M; Gerull S; Medinger M; Passweg J; Schanz U; Garzoni C; Berger C; Chalandon Y; Mueller NJ; van Delden C; Neofytos D; Khanna N;
Transpl Infect Dis; 2018 Dec; 20(6):e12981. PubMed ID: 30144374
[TBL] [Abstract][Full Text] [Related]
11. Breakthrough Invasive Fungal Infections in Patients with Acute Myeloid Leukemia.
Wasylyshyn A; Linder KA; Castillo CG; Zhou S; Kauffman CA; Miceli MH
Mycopathologia; 2020 Apr; 185(2):299-306. PubMed ID: 31939052
[TBL] [Abstract][Full Text] [Related]
12. Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil.
Nucci M; Garnica M; Gloria AB; Lehugeur DS; Dias VC; Palma LC; Cappellano P; Fertrin KY; Carlesse F; Simões B; Bergamasco MD; Cunha CA; Seber A; Ribeiro MP; Queiroz-Telles F; Lee ML; Chauffaille ML; Silla L; de Souza CA; Colombo AL
Clin Microbiol Infect; 2013 Aug; 19(8):745-51. PubMed ID: 23009319
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology and risk factors for invasive fungal disease in liver transplant recipients in a tertiary transplant center.
Lum L; Lee A; Vu M; Strasser S; Davis R
Transpl Infect Dis; 2020 Dec; 22(6):e13361. PubMed ID: 32510755
[TBL] [Abstract][Full Text] [Related]
14. Impact of treatment intensity on infectious complications in patients with acute myeloid leukemia.
Tober R; Schnetzke U; Fleischmann M; Yomade O; Schrenk K; Hammersen J; Glaser A; Thiede C; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1569-1583. PubMed ID: 35583829
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
[TBL] [Abstract][Full Text] [Related]
16. Decreased invasive fungal disease but no impact on overall survival by posaconazole compared to fluconazole prophylaxis: a retrospective cohort study in patients receiving induction therapy for acute myeloid leukaemia/myelodysplastic syndromes.
Dahlén T; Kalin M; Cederlund K; Nordlander A; Björkholm M; Ljungman P; Blennow O
Eur J Haematol; 2016 Feb; 96(2):175-80. PubMed ID: 25880378
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of antifungal prophylaxis with oral suspension posaconazole during induction chemotherapy of acute myeloid leukemia.
Schrenk KG; Schnetzke U; Stegemann K; von Lilienfeld-Toal M; Hochhaus A; Scholl S
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1661-8. PubMed ID: 25800622
[TBL] [Abstract][Full Text] [Related]
18. Invasive fungal diseases in patients with acute lymphoid leukemia.
Nicolato A; Nouér SA; Garnica M; Portugal R; Maiolino A; Nucci M
Leuk Lymphoma; 2016 Sep; 57(9):2084-9. PubMed ID: 26949001
[TBL] [Abstract][Full Text] [Related]
19. Risk Factors, Prevalence, and Outcomes of Invasive Fungal Disease Post Hematopoietic Cell Transplantation and Cellular Therapies: A Retrospective Monocenter Real-Life Analysis.
Gavriilaki E; Dolgyras P; Dimou-Mpesikli S; Poulopoulou A; Evangelidis P; Evangelidis N; Demosthenous C; Zachrou E; Siasios P; Mallouri D; Vardi A; Bousiou Z; Panteliadou A; Batsis I; Masmanidou M; Lalayanni C; Yannaki E; Sotiropoulos D; Anagnostopoulos A; Vyzantiadis TA; Sakellari I
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444639
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of Antifungal Prophylaxis in High-Risk Haematological Patients (AML under Intensive Chemotherapy): The SAPHIR Prospective Multicentre Study.
Gangneux JP; Padoin C; Michallet M; Saillio E; Kumichel A; Peffault de La Tour R; Ceballos P; Gastinne T; Pigneux A
J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33198192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]